| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.08B | 1.01B | 921.55M | 816.28M | 775.64M |
| Gross Profit | 152.35M | 141.66M | 135.05M | 115.82M | 102.72M |
| EBITDA | 86.33M | 80.10M | 75.16M | 67.19M | 58.54M |
| Net Income | 48.81M | 41.57M | 43.38M | 37.66M | 30.46M |
Balance Sheet | |||||
| Total Assets | 530.65M | 547.71M | 449.63M | 400.86M | 374.12M |
| Cash, Cash Equivalents and Short-Term Investments | 6.22M | 80.22M | 35.66M | 27.56M | 881.00K |
| Total Debt | 27.73M | 76.58M | 17.68M | 21.86M | 30.21M |
| Total Liabilities | 289.51M | 341.32M | 270.24M | 252.18M | 249.30M |
| Stockholders Equity | 241.14M | 206.39M | 179.40M | 148.68M | 124.82M |
Cash Flow | |||||
| Free Cash Flow | 53.16M | 38.29M | 48.63M | 52.39M | 35.20M |
| Operating Cash Flow | 59.02M | 44.44M | 54.14M | 57.44M | 39.25M |
| Investing Cash Flow | -52.13M | -30.66M | -17.22M | -3.54M | -36.12M |
| Financing Cash Flow | -78.35M | 28.25M | -21.12M | -24.33M | -25.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.36B | 8.23 | 23.46% | 3.08% | -1.17% | 12.31% | |
78 Outperform | £496.86M | 11.49 | 13.06% | 1.88% | -12.98% | 5.51% | |
73 Outperform | £672.10M | 13.13 | 21.11% | 2.16% | 7.13% | 17.31% | |
73 Outperform | £1.98B | 12.50 | 24.53% | 2.49% | 6.93% | 21.50% | |
72 Outperform | £491.47M | 7.10 | 27.48% | 3.65% | 5.78% | -6.80% | |
71 Outperform | £879.13M | 9.81 | 11.69% | 3.19% | 4.40% | 31.59% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |